Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;35(1):e23657.
doi: 10.1002/jcla.23657. Epub 2020 Nov 22.

Peripheral blood inflammatory markers in predicting prognosis in patients with COVID-19. Some differences with influenza A

Yan Zhao  1   2 , Chao Yu  1   2 , Wei Ni  1   2 , Hua Shen  1   2 , Mengqi Qiu  1   2 , Youyun Zhao  1   2
Affiliations

Peripheral blood inflammatory markers in predicting prognosis in patients with COVID-19. Some differences with influenza A

Yan Zhao et al. J Clin Lab Anal. 2021 Jan.

Abstract

Background: To evaluate the ability of peripheral blood inflammatory markers in predicating the typing of COVID-19, prognosis, and some differences between COVID-19 and influenza A patients.

Methods: Clinical data on 285 cases laboratory-confirmed as SARS-CoV-2 infection were obtained from a Wuhan local hospital's electronic medical records according to previously designed standardized data collection forms. Additional 446 Influenza A outpatients' hematologic data were enrolled for comparison.

Results: NLR, SII, RLR, PLR, HsCRP, and IL-6 were significant higher and LMR was lower in severe COVID-19 patients than in mild COVID-19 patients (p < .001). PLR and LMR were lower in the individuals with influenza A than those with COVID-19 (p < .01). COVID-19 patients with higher levels of NLR, SII, RLR, PLR, HsCRP, and IL-6 and lower LMR were significantly associated with the severe type. AUC of NLR (0.76) was larger while the specificity of IL-6 (86%) and sensitivity of HsCRP (89%) were higher than other inflammatory markers in predicating the typing of COVID-19. PT had obvious correlation with all the inflammatory markers except RPR. NLR showed positive correlations with AST, TP, BUN, CREA, PT, and D-dimer. Patients with high IL-6 levels have a relatively worse prognosis (HR = 2.30).

Conclusion: Peripheral blood inflammatory markers reflected the intensity of inflammation and associated with severity of COVID-19.NLR was more useful to predict severity as well as IL-6 to predict prognosis of COVID-19. PLR and LMR were initially found to be higher in SARS-CoV-2 virus-infected group than in influenza A.

Keywords: COVID-19; SARS-CoV-2; inflammatory markers; influenza A.

PubMed Disclaimer

Conflict of interest statement

The authors disclose no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
A‐G: Receiver operating characteristic (ROC) curve and Cutoff value of NLR, SII, RLR, PLR, LMR, HsCRP, IL‐6 in differentiating type of COVID‐19
See this image and copyright information in PMC

References

    1. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708‐1720. 10.1056/NEJMoa2002032 - DOI - PMC - PubMed
    1. Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265‐269. 10.1038/s41586-020-2008-3 - DOI - PMC - PubMed
    1. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270‐273. 10.1038/s41586-020-2012-7 - DOI - PMC - PubMed
    1. Cowling BJ, Leung GM. Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019‐nCoV) outbreak. Euro Surveill. 2020;25(6):2000110 10.2807/1560-7917.ES.2020.25.6.2000110 - DOI - PMC - PubMed
    1. Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS‐Cov‐2) outside of Wuhan, China: retrospective case series. BMJ. 2020;m606 10.1136/bmj.m606 - DOI - PMC - PubMed

LinkOut - more resources